natgillin/translations-raw huggingface dataset:
What you need to know before you take Neoclarityn 
Kaj morate vedeti, preden boste vzeli zdravilo Neoclarityn
● feeling sick (nausea) 
● bolečine v želodcu ● občutek slabosti (siljenje na bruhanje)
Neoclarityn is indicated in adults, adolescents and children over the age of 1 year for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1) 
Zdravilo Neoclarityn je indicirano pri odraslih, mladostnikih in otrocih, starejših od 1 leta, za lajšanje simptomov: - alergijskega rinitisa (glejte poglavje 5.1) - urtikarije (glejte poglavje 5.1)
Children 6 through 11 years of age: 5 ml (2.5 mg) Neoclarityn oral solution once a day. 
Otroci v starosti od 6 do 11 let: 5 ml (2,5 mg) peroralne raztopine Neoclarityn enkrat na dan.
Neoclarityn 2.5 mg orodispersible tablet is light red, speckled, and round with “K” branded on one side. 
Neoclarityn 2,5 mg orodisperzibilne tablete so svetlo rdeče okrogle pikčaste tablete z oznako K na eni strani.
Neoclarityn orodispersible tablet is an antiallergy medicine that does not make you drowsy. 
Zdravilo Neoclarityn orodisperzibilna tableta je zdravilo proti alergiji, ki ne povzroča zaspanosti.
Neoclarityn is indicated in adults, adolescents aged 12 years and older and children aged 6 - 11 years old for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1) 
Zdravilo Neoclarityn je indicirano pri odraslih, mladostnikih, starih 12 let in več, in otrocih, starih 611 let, za lajšanje simptomov: - alergijskega rinitisa (glejte poglavje 5.1) - urtikarije (glejte poglavje 5.1)
Neoclarityn tablets were effective in alleviating the burden of seasonal allergic rhinitis as shown by the total score of the rhino-conjunctivitis quality of life questionnaire. 
Zdravilo Neoclarityn je učinkovito ublažilo težave, povezane s sezonskim alergijskim rinitisom, kar so pokazali skupni rezultati vprašalnika o kakovosti življenja bolnikov z rinitisom in konjunktivitisom.
● upset stomach 
● razdražen želodec ● driska
If you take more Neoclarityn oral solution than you should Take Neoclarityn oral solution only as it is prescribed for you. 
Če ste vzeli večji odmerek zdravila Neoclarityn, kot bi smeli Zdravilo Neoclarityn jemljite le tako, kot vam je bilo predpisano.
Do not take Neoclarityn orodispersible tablet - if you are allergic to desloratadine, or any of the other ingredients of this medicine (listed in section 6) or to loratadine. 
Ne uporabljajte zdravila Neoclarityn orodisperzibilna tableta - če ste alergični na desloratadin ali katero koli sestavino tega zdravila (navedeno v poglavju 6)
Neoclarityn contains lactose 
Zdravilo Neoclarityn vsebuje laktozo
What Neoclarityn looks like and contents of the pack 
Izgled zdravila Neoclarityn in vsebina pakiranja
propylene glycol, sucralose E 955, hypromellose 2910, sodium citrate dihydrate, natural and artificial flavour (bubblegum), citric acid anhydrous, disodium edetate, purified water 
6.1 Seznam pomožnih snovi sorbitol, propilenglikol, sukraloza E 955, hipromeloza 2910, natrijev citrat dihidrat, naravna in umetna aroma (žvečilni gumi), brezvodna citronska kislina, dinatrijev edetat, prečiščena voda
Neoclarityn was effective in alleviating the burden of seasonal allergic rhinitis as shown by the total score of the rhino-conjunctivitis quality of life questionnaire. 
Zdravilo Neoclarityn je učinkovito ublažilo težave, povezane s sezonskim alergijskim rinitisom, kar je pokazal skupni rezultat vprašalnika o kakovosti življenja bolnikov z rinitisom in konjunktivitisom.
Neoclarityn oral solution with food, drink and alcohol Neoclarityn may be taken with or without a meal. 
Zdravilo Neoclarityn peroralna raztopina skupaj s hrano, pijačo in alkoholom Zdravilo Neoclarityn se lahko jemlje s hrano ali brez nje.
Neoclarityn oral solution contains sorbitol. 
Zdravilo Neoclarityn peroralna raztopina vsebuje sorbitol Neoclarityn peroralna raztopina vsebuje sorbitol.
What Neoclarityn oral solution is and what it is used for What you need to know before you take Neoclarityn oral solution How to take Neoclarityn oral solution Possible side effects 
Kaj je zdravilo Neoclarityn in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Neoclarityn Kako jemati zdravilo Neoclarityn Možni neželeni učinki
How to take Neoclarityn orodispersible tablet 
Kako jemati zdravilo Neoclarityn orodisperzibilna tableta
If you stop taking Neoclarityn orodispersible tablet If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse. 
Če ste prenehali jemati zdravilo Neoclarityn orodisperzibilna tableta Če imate dodatna vprašanja o uporabi zdravila, se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro.
Neoclarityn is indicated in adults and adolescents aged 12 years and older for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1) 
Zdravilo Neoclarityn je indicirano pri odraslih in mladostnikih, starih 12 let in več, za lajšanje simptomov: - alergijskega rinitisa (glejte poglavje 5.1) - urtikarije (glejte poglavje 5.1)
Neoclarityn is supplied in blisters comprised of laminate blister film with foil lidding. 
Neoclarityn je na voljo v laminatnih pretisnih omotih , ki ga sestavljata film pretisnega, omota in folija, ki ga prekriva.
Neoclarityn tablets given at a single daily dose of 7.5 mg to adults and adolescents did not affect psychomotor performance in clinical trials. 
V kliničnih preskušanjih zdravilo Neoclarityn v enem dnevnem odmerku 7,5 mg pri odraslih in mladostnikih ni vplivalo na psihomotorične sposobnosti bolnikov.
Do not take Neoclarityn - if you are allergic to desloratadine, or any of the other ingredients of this medicine (listed in section 6) or to loratadine. 
Ne uporabljajte zdravila Neoclarityn - če ste alergični na desloratadin ali katero koli sestavino tega zdravila (navedeno v poglavju 6)
● rash 
• driska
If you stop taking Neoclarityn If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse. 
Če ste prenehali jemati zdravilo Neoclarityn Če imate dodatna vprašanja o uporabi zdravila, se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro.
The safety and efficacy of Neoclarityn 0.5 mg/ml oral solution in children below the age of 1 year have not been established. 
Varnost in učinkovitost zdravila Neoclarityn 0,5 mg/ml peroralna raztopina pri otrocih, mlajših od 1 leta, nista bili dokazani.
Neoclarityn orodispersible tablet is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy). 
Zdravilo Neoclarityn orodisperzibilna tableta se uporablja tudi za lajšanje simptomov urtikarije (težave s kožo zaradi alergije).
The safety and efficacy of Neoclarityn 5 mg film-coated tablets in children below the age of 12 years have not been established. 
Varnost in učinkovitost zdravila Neoclarityn 5 mg filmsko obložene tablete pri otrocih, mlajših od 12 let, nista bili dokazani.
In a clinical trial with 578 adolescent patients, 12 through 17 years of age, the most common adverse event was headache; this occurred in 5.9 % of patients treated with desloratadine and 6.9 % of patients receiving placebo. 
Ta se je pojavil pri 5,9 % bolnikov, zdravljenih z desloratadinom, in pri 6,9 % bolnikov, zdravljenih s placebom.
Neoclarityn is an antiallergy medicine that does not make you drowsy. 
Zdravilo Neoclarityn je zdravilo proti alergiji, ki ne povzroča zaspanosti.
In clinical trials in a range of indications including allergic rhinitis and chronic idiopathic urticaria, at the recommended dose of 5 mg daily, undesirable effects with Neoclarityn tablets were reported in 3 % of patients in excess of those treated with placebo. 
V kliničnih preskušanjih pri različnih indikacijah za uporabo zdravila, vključno z alergijskim rinitisom in kronično idiopatsko urtikarijo, so pri priporočenem odmerku 5 mg na dan o neželenih učinkih tablet Neoclarityn poročali pri 3 % bolnikov več kot pri tistih, ki so bili zdravljeni s placebom.
The safety and efficacy of Neoclarityn 2.5 mg orodispersible tablets in children below the age of 6 years have not been established. 
Varnost in učinkovitost zdravila Neoclarityn 2,5 mg orodisperzibilne tablete pri otrocih, mlajših od 6 let, nista bili dokazani.
Neoclarityn 5 mg orodispersible tablet is light red, speckled, and round with “A” branded on one side. 
Neoclarityn 5 mg orodisperzibilne tablete so svetlo rdeče okrogle pikčaste tablete z oznako A na eni strani.
Neoclarityn orodispersible tablet is packed in unit dose blisters in packs of 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90 and 100 doses of orodispersible tablet. 
Neoclarityn orodisperzibilne tablete so na voljo v pretisnih omotih po 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90 in 100 orodisperzibilnih tablet.
BOX OF 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50, 100 TABLETS 
ŠKATLA PO 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50, 100 TABLET
At the recommended dose, in clinical trials involving adults and adolescents in a range of indications including allergic rhinitis and chronic idiopathic urticaria, undesirable effects with Neoclarityn were reported in 3 % of patients in excess of those treated with placebo. 
V kliničnih preskušanjih pri odraslih in mladostnikih za različne indikacije, vključno z alergijskim rinitisom in kronično idiopatsko urtikarijo, so pri priporočenem odmerku o neželenih učinkih zdravila Neoclarityn poročali pri 3 % bolnikov več kot pri tistih, ki so bili zdravljeni s placebom.
Neoclarityn is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy). 
Zdravilo Neoclarityn se uporablja tudi za lajšanje simptomov urtikarije (težave s kožo zaradi alergije).
In adult and adolescent patients with allergic rhinitis, Neoclarityn tablets were effective in relieving symptoms such as sneezing, nasal discharge and itching, as well as ocular itching, tearing and redness, and itching of palate. 
Pri odraslih in mladostnikih z alergijskim rinitisom zdravilo Neoclarityn tablete učinkovito lajša simptome, kakor so kihanje, iztok iz nosa in srbenje, pa tudi srbenje oči, solzenje in vnetje očesne veznice ter srbenje ustnega neba.
Packs of 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50, 100 tablets. 
Pakiranja po 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50 ali 100 tablet.
What Neoclarityn contains 
Kaj vsebuje zdravilo Neoclarityn
How to store Neoclarityn oral solution Contents of the pack and other information 
Shranjevanje zdravila Neoclarityn Vsebina pakiranja in dodatne informacije
In clinical trials in a range of indications including allergic rhinitis and chronic idiopathic urticaria, at the recommended dose of 5 mg daily, undesirable effects with Neoclarityn were reported in 3 % of patients in excess of those treated with placebo. 
V kliničnih preskušanjih pri različnih indikacijah za uporabo zdravila, vključno z alergijskim rinitisom in kronično idiopatsko urtikarijo, so pri priporočenem odmerku 5 mg na dan o neželenih učinkih zdravila Neoclarityn poročali pri 3 % bolnikov več kot pri tistih, ki so bili zdravljeni s placebom.
Neoclarityn tablets given at a single daily dose of 7.5 mg did not affect psychomotor performance in clinical trials. 
V kliničnih preskušanjih tablete Neoclarityn v enem dnevnem odmerku 7,5 mg niso vplivale na psihomotorične sposobnosti bolnikov.
Neoclarityn 0.5 mg/ml oral solution desloratadine 
Neoclarityn 0,5 mg/ml peroralna raztopina desloratadin
If you stop taking Neoclarityn oral solution If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse. 
Če ste prenehali jemati zdravilo Neoclarityn peroralna raztopina Če imate dodatna vprašanja o uporabi zdravila, se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro.
How to take Neoclarityn 
Kako jemati zdravilo Neoclarityn
This product contains 1.4 mg of phenylalanine per 2.5 mg dose of Neoclarityn orodispersible tablet. 
Neoclarityn orodisperzibilne tablete vsebujejo 1,4 mg fenilalanina na 2,5 mg odmerek zdravila.
In patients with allergic rhinitis, Neoclarityn tablets were effective in relieving symptoms such as sneezing, nasal discharge and itching, as well as ocular itching, tearing and redness, and itching of palate. 
Pri bolnikih z alergijskim rinitisom tablete Neoclarityn učinkovito lajšajo simptome, kakor so kihanje, iztok iz nosa in srbenje, pa tudi srbenje oči, solzenje in vnetje očesne veznice ter srbenje ustnega neba.
The safety and efficacy of Neoclarityn 5 mg orodispersible tablets in children below the age of 12 years have not been established. 
Varnost in učinkovitost zdravila Neoclarityn 5 mg orodisperzibilne tablete pri otrocih, mlajših od 12 let, nista bili dokazani.
Neoclarityn 5 mg film-coated tablets 
Neoclarityn 5 mg filmsko obložene tablete
This product contains 2.9 mg of phenylalanine per 5 mg dose of Neoclarityn orodispersible tablet. 
Neoclarityn orodisperzibilne tablete vsebujejo 2,9 mg fenilalanina na 5 mg odmerek zdravila.
Neoclarityn 0.5 mg/ml oral solution 
Neoclarityn 0,5 mg/ml peroralna raztopina
What Neoclarityn orodispersible tablet looks like and contents of the pack 
Izgled zdravila Neoclarityn orodisperzibilna tableta in vsebina pakiranja
In patients with allergic rhinitis, Neoclarityn was effective in relieving symptoms such as sneezing, nasal discharge and itching, as well as ocular itching, tearing and redness, and itching of palate. 
Pri bolnikih z alergijskim rinitisom zdravilo Neoclarityn učinkovito lajša simptome, kakor so kihanje, iztok iz nosa in srbenje, pa tudi srbenje oči, solzenje in vnetje očesne veznice ter srbenje ustnega neba.
How to store Neoclarityn 
Shranjevanje zdravila Neoclarityn
Neoclarityn given at a single daily dose of 7.5 mg did not affect psychomotor performance in clinical trials. 
V kliničnih preskušanjih zdravilo Neoclarityn v enem dnevnem odmerku 7,5 mg ni vplivalo na psihomotorične sposobnosti bolnikov.
How Neoclarityn works 
Kako deluje zdravilo Neoclarityn
Clinical efficacy and safety In a multiple dose trial, Neoclarityn orodispersible tablets were well tolerated. 
V preskušanju večkratnega odmerjanja so bolniki zdravilo Neoclarityn orodisperzibilne tablete dobro prenašali.
Neoclarityn 5 mg film-coated tablets desloratadine 
Neoclarityn 5 mg filmsko obložene tablete desloratadin
Neoclarityn oral solution is an antiallergy medicine that does not make you drowsy. 
Zdravilo Neoclarityn peroralna raztopina je zdravilo proti alergiji, ki ne povzroča zaspanosti.
How to store Neoclarityn orodispersible tablet 
Shranjevanje zdravila Neoclarityn orodisperzibilna tableta
Neoclarityn oral solution is available in bottles of 30, 50, 60, 100, 120, 150, 225 and 300 ml, with a childproof cap. For all packages except the 150 ml bottle, a measuring spoon is provided, marked for doses of 2.5 ml and 5 ml. 
Neoclarityn peroralna raztopina je na voljo v stekleničkah po 30, 50, 60, 100, 120, 150, 225 in 300 ml, z zaporko, varno za otroke.
What you need to know before you take Neoclarityn oral solution 
Kaj morate vedeti, preden boste vzeli zdravilo Neoclarityn peroralna raztopina
Neoclarityn 2.5 mg orodispersible tablets 
Neoclarityn 2,5 mg orodisperzibilne tablete
Neoclarityn 5 mg orodispersible tablets 
Neoclarityn 5 mg orodisperzibilna tableta
Neoclarityn 2.5 mg orodispersible tablets desloratadine 
Neoclarityn 2,5 mg orodisperzibilne tablete desloratadin
Neoclarityn orodispersible tablet relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites) in adults, adolescents and children 6 years of age and older. 
Zdravilo Neoclarityn orodisperzibilna tableta lajša simptome alergijskega rinitisa (vnetje nosnih poti zaradi alergije, na primer seneni nahod ali alergija na pršice) pri odraslih, mladostnikih in otrocih, starih 6 let in več.
What Neoclarityn oral solution is and what it is used for 
Kaj je zdravilo Neoclarityn peroralna raztopina in za kaj ga uporabljamo
Neoclarityn oral solution relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites) in adults, adolescents and children 1 year of age and older. 
Zdravilo Neoclarityn peroralna raztopina lajša simptome alergijskega rinitisa (vnetje nosnih poti zaradi alergije, na primer seneni nahod ali alergija na pršice) pri odraslih, mladostnikih in otrocih, starih 1 leto in več.
Neoclarityn 5 mg orodispersible tablets desloratadine 
Neoclarityn 5 mg orodisperzibilne tablete desloratadin
Neoclarityn 2.5 mg orodispersible tablet 
Neoclarityn 2,5 mg orodisperzibilna tableta
Neoclarityn orodispersible tablet relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites) in adults and adolescents 12 years of age and older. 
Zdravilo Neoclarityn orodisperzibilna tableta lajša simptome alergijskega rinitisa (vnetje nosnih poti zaradi alergije, na primer seneni nahod ali alergija na pršice) pri odraslih in mladostnikih, starih 12 let in več.
Neoclarityn relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites) in adults and adolescents 12 years of age and older. 
Zdravilo Neoclarityn lajša simptome alergijskega rinitisa (vnetje nosnih poti zaradi alergije, na primer seneni nahod ali alergija na pršice) pri odraslih in mladostnikih, starih 12 let in več.
What Neoclarityn orodispersible tablet contains 
Kaj vsebuje zdravilo Neoclarityn orodisperzibilna tableta
The recommended dose is 2.5 ml (½ of a 5 ml spoonful) of oral solution once a day. 
Priporočeni odmerek zdravila Neoclarityn je 10 ml (5 mg) peroralne raztopine enkrat na dan.
Date of first authorisation: 21 February 2005 Date of latest renewal: 19 January 2010 
Datum prve odobritve: 21. februar 2005 Datum zadnjega podaljšanja: 19. januar 2010
How to prepare a new bottle of medicine for first time use: 
Kako pripraviti novo steklenico zdravila za prvo uporabo:
Follow the instructions below: 
Upoštevajte spodnja navodila:
Important information about instructions for use: 
Pomembna informacija o navodilih za uporabo:
The dose that your doctor prescribes you should be given in ml of suspension and not in mg. 
Odmerek, ki vam ga predpiše zdravnik, je treba dati v ml suspenzije in ne v mg.
The clinical study was open-labelled and uncontrolled. 
Klinična študija je bila odprta in nenadzorovana.
Monitoring visits should be performed every 6 months; shorter intervals between visits are recommended in case of adverse events. 
Kontrolni pregledi naj bod izvedeni vsakih 6 mesecev, krajši razmiki med posameznimi obiski so priporočljivi v primeru neželenih dogodkov.
Orfadin must not be injected. 
Zdravila Orfadin se ne sme injicirati.
Re-dispersing is required before each use by vigorous shaking. 
Pred vsako uporabo je potrebna redisperzija z močnim stresanjem.
Turn the bottle to an upright position again. 
Obrnite steklenico spet v pokončen položaj.
The dose should be withdrawn and administered immediately after re-dispersion. 
Odmerek je treba izvleči in dati takoj po redisperziji.
Orfadin should not be used during pregnancy unless the clinical condition of the woman requires treatment with nitisinone. 
Zdravila Orfadin ne smete uporabljati med nosečnostjo, razen če klinično stanje nosečnice zahteva zdravljenje z nitizinonom.
In an international survey of patients with HT-1 on treatment with dietary restriction alone, it was found that HCC had been diagnosed in 18% of all patients aged 2 years and above. 
V mednarodni študiji pri bolnikih s HT-1 o zdravljenju zgolj s predpisano dieto so ugotovili, da je bila diagnoza HCK postavljena pri 18 % vseh bolnikov, starih 2 leti in več.
However, if you experience side effects affecting your vision you should not drive or use machines until your vision is back to normal (see section 4“Possible side effects”). 
Če pa se pri jemanju pojavijo neželeni učinki, ki vplivajo na vid, ne smete voziti ali upravljati strojev, dokler se vaš vid ne normalizira (glejte poglavje 4 »Možni neželeni učinki«).
From clinical study and post marketing data there are no indications that the safety profile is different in different subsets of the paediatric population or different from the safety profile in adult patients. 
Iz kliničnih študij in iz podatkov v obdobju trženja zdravila se pri nobeni indikaciji ne pokaže različen varnostni profil pri različnih podskupinah pediatričnih bolnikov ali drugačen varnostni profil glede na odrasle bolnike.
A population pharmacokinetic analysis has been conducted on a group of 207 HT-1 patients. 
Populacijske farmakokinetične analize so bile izvedene na skupini 207 bolnikov s HT-1.
Orfadin is also available as a 4 mg/ml oral suspension for paediatric patients who have difficulties swallowing capsules. 
Zdravilo Orfadin je na voljo tudi kot 4 mg/ml peroralna suspenzija za pediatrične bolnike, ki imajo težave pri požiranju kapsul.
What Orfadin is and what it is used for 
Kaj je zdravilo Orfadin in za kaj ga uporabljamo
What Orfadin is and what it is used for What you need to know before you take Orfadin How to take Orfadin 
Kaj je zdravilo Orfadin in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Orfadin Kako jemati zdravilo Orfadin
Age at onset of symptoms 1 year 2 years < 2 months > 2-6 months > 6 months 
Starost pri pojavu simptomov 1 leto 2 leti < 2 meseca > 2-6 mesecev > 6 mesecev
Oral suspension 90 ml 
peroralna suspenzija 90 ml
Orfadin may interfere with the effect of other medicines, such as: - Medicines for epilepsy (such as phenytoin) - Medicines against blood clotting (such as warfarin) 
Zdravilo Orfadin lahko vpliva na delovanje drugih zdravil, kot so: - zdravila za epilepsijo (kot je fenitoin) - zdravila proti strjevanju krvi (kot je varfarin)
Do not attach a needle to the syringe. 
Na brizgo ne pritrdite igle.
The dose recommendation in mg/kg body weight is the same in children and adults. 
Pediatrična populacija Priporočeni odmerek v mg/kg telesne mase je enak za otroke in odrasle.
It is recommended that the oral suspension is taken with food. 
Priporočljivo je, da se peroralna suspenzija jemlje s hrano.
It is important that you use the correct oral syringe when taking the medicine. 
Pomembno je, da uporabite pravo brizgo za peroralno dajanje , ko vzamete zdravilo.
Follow-up by your doctor should be performed every 6 months. 
Vsakih 6 mesecev mora zdravnik opraviti kontrolni pregled.
Other medicines and Orfadin 
Druga zdravila in zdravilo Orfadin
Age at start of treatment 2 years 4 years 6 years 
Starost na začetku zdravljenja 2 leti 4 leta 6 let
If you start treatment by taking it with food, it is recommended that you carry on taking it with food throughout your course of treatment. 
Če boste zdravljenje začeli z jemanjem tega zdravila s hrano je priporočljivo, da tako nadaljujete ves čas zdravljenja.
How to prepare a dose of medicine 
Kako pripraviti odmerek zdravila
Increase in serum alpha-fetoprotein concentration may be a sign of inadequate treatment. 
Povečanje koncentracije alfa-fotoproteina je lahko znak neustreznega zdravljenja.
The bottle adapter should not be removed. 
Nastavek za steklenico se ne sme odstraniti.
This is because the oral syringe which is used to withdraw the correct dose from the bottle is marked in ml. 
To pa zato, ker ima brizga za peroralno dajanje, ki se uporablja za odvzem pravilnega odmerka iz steklenice, oznake v ml.
No information about specific treatment of overdose is available. 
Ni podatkov o specifičnosti zdravljenja v primeru prevelikega odmerjanja.
Food does not influence the bioavailability of nitisinone oral suspension, but intake together with food decreases the absorption rate and consequently leads to lower fluctuations in serum concentrations within a dosage interval. 
Hrana ne vpliva na biološko uporabnost peroralne suspenzije nitizinona, vendar jemanje skupaj s hrano zmanjša hitrost absorpcije in posledično povzroči nižje fluktuacije v serumskih koncentracijah znotraj intervala odmerjanja.